Information Provided By: 
Fly News Breaks for July 8, 2016
NEO
Jul 8, 2016 | 08:00 EDT
Craig-Hallum analyst Bill Bonello said CMS' proposed Physician Fee Schedule rates for key codes billed by NeoGenomics are substantially better than he had projected, which provides "some cushion" to his 2017 estimates for the company. Given the better than expected rates, Bonello raised his price target on NeoGenomics shares to $12 from $10 and reiterates a Buy rating on the stock.
News For NEO From the Last 2 Days
There are no results for your query NEO
